A Dose Ranging Study of the Effect of Ruxolitinib Phosphate Cream When Applied to Participants With Plaque Psoriasis
Part of paid clinical trials in Hot Springs, Arkansas.
- Sponsor
- Incyte Corporation
- Study ID
- NCT00778700
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Placebo Cream — OTHERCream with no active drug
- Ruxolitinib Phosphate — DRUGRuxolitinib phosphate cream
Study Details
The study was double-blind, randomized, vehicle-controlled study with application of Ruxolitinib phosphate cream or vehicle cream in participants with stable plaque psoriasis applied once daily for 12 weeks without occlusive dressings. There were 4 treatment groups anticipated to have 50 participants in each.
Key Dates
- Start date
- Oct 28, 2008
- Status verified
- Jan 2022
- Primary completion
- Jun 26, 2009
- Completion
- Jun 26, 2009
Study Design
- Enrollment
- 199 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Placebo Comparator: Vehicle CreamVehicle cream, applied topically, once daily from Day 1 to Week 12.
- Experimental: Ruxolitinib Phosphate 0.5% CreamRuxolitinib phosphate 0.5% cream, applied topically, once daily from Day 1 to Week 12.
- Experimental: Ruxolitinib Phosphate 1.0% CreamRuxolitinib phosphate 1.0% cream, applied topically, once daily from Day 1 to Week 12.
- Experimental: Ruxolitinib Phosphate 1.5% CreamRuxolitinib phosphate 1.5% cream, applied topically, once daily from Day 1 to Week 12.
Primary Outcome Measure
Absolute Change From Baseline in Total Lesion Score for All Treatable Psoriatic Lesions to Day 84 [ Time Frame: From Baseline (Day 1) to Day 84 ]
Locations (28)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| - | Hot Springs | Arkansas | - | - |
| - | Los Angeles | California | - | - |
| - | San Diego | California | - | - |
| - | Santa Monica | California | - | - |
| - | Vallejo | California | - | - |
| - | New Haven | Connecticut | - | - |
| - | Miami | Florida | - | - |
| - | Ormond Beach | Florida | - | - |
| - | Naperville | Illinois | - | - |
| - | Wheaton | Illinois | - | - |
| - | Evansville | Indiana | - | - |
| - | South Bend | Indiana | - | - |
| - | Boston | Massachusetts | - | - |
| - | Clinton Township | Michigan | - | - |
| - | Fridley | Minnesota | - | - |
| - | St Louis | Missouri | - | - |
| - | Albuquerque | New Mexico | - | - |
| - | Rochester | New York | - | - |
| - | Norman | Oklahoma | - | - |
| - | Simpsonville | South Carolina | - | - |
| - | Austin | Texas | - | - |
| - | College Station | Texas | - | - |
| - | Dallas | Texas | - | - |
| - | Houston | Texas | - | - |
| - | Salt Lake City | Utah | - | - |
| - | Norfolk | Virginia | - | - |
| - | Walla Walla | Washington | - | - |
| - | Madison | Wisconsin | - | - |
Find similar trials in Hot Springs, AR
By condition
By specialty
Related Studies
- Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy ProjectRecruiting · University of California, San Diego · La Jolla, California
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque PsoriasisPHASE4 · Recruiting · Bausch Health Americas, Inc. · Fountain Valley, California
- Skin Microbial Ecology in Atopic DermatitisRecruiting · University of Rochester · Rochester, New York